Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation?*

Background A recent “ex-vivo” study showed that nonvalvular atrial fibrillation (NVAF) is associated with enhanced activity of metalloproteinases at the atrial level, and in animal models homocysteine (Hcy) is able…

Continue ReadingHyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation?*